Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
This study is currently recruiting participants.
Verified March 2012 by LANG Jin-yi, The Second People's Hospital of Sichuan
The Second People's Hospital of Sichuan
Biotech Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
LANG Jin-yi, The Second People's Hospital of Sichuan
First received: January 11, 2012
Last updated: March 18, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||March 2018|
|Estimated Primary Completion Date:||September 2013 (Final data collection date for primary outcome measure)|